Biotech Values

[Mufaso]

RVNC- Judging from all of the news services that have gotten the RT002 story wrong or are amplifying the Allergan spin, I think the commercial battle will be very difficult. I have no doubts that AGN has already been targeting doctors and getting their message out.

An ounce of prevention is worth a pound of cure. Having RVNC early on the sales effort is much better than being late IMO. I'm glad RVNC management is taking this approach and think the sales funds spent now will pay off.